Authors:
Masquelier, B
Neau, D
Chene, G
Larbere, J
Birac, V
Ragnaud, JM
Fleury, HJA
Citation: B. Masquelier et al., Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA, J ACQ IMM D, 28(4), 2001, pp. 309-312
Authors:
Le Moing, V
Chene, G
Carrieri, MP
Besnier, JM
Masquelier, B
Salamon, R
Bazin, C
Moatti, JP
Raffi, F
Leport, C
Citation: V. Le Moing et al., Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors, J ACQ IMM D, 27(4), 2001, pp. 372-376
Authors:
Masquelier, B
Chaix, ML
Burgard, M
Lechenadec, J
Doussin, A
Simon, F
Cottalorda, J
Izopet, J
Tamalet, C
Douard, D
Fleury, H
Mayaux, MJ
Blanche, S
Rouzioux, C
Citation: B. Masquelier et al., Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort, J ACQ IMM D, 27(2), 2001, pp. 99-104
Authors:
Descamps, D
Calvez, V
Izopet, J
Bluffet-Janvresse, C
Schmuck, A
Colson, P
Ruffault, A
Maillard, A
Masquelier, B
Cottalorda, J
Harzic, M
Brun-Vezinet, F
Costagliola, D
Citation: D. Descamps et al., Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study, AIDS, 15(14), 2001, pp. 1777-1782
Authors:
Masquelier, B
Race, E
Tamalet, C
Descamps, D
Izopet, J
Buffet-Janvresse, C
Ruffault, A
Mohammed, AS
Cottalorda, J
Schmuck, A
Calvez, V
Dam, E
Fleury, H
Brun-Vezinet, F
Citation: B. Masquelier et al., Genotypic and penotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase(RT): Multicenter study of patients treated with RT inhibitors, ANTIM AG CH, 45(6), 2001, pp. 1836-1842
Authors:
Le Moing, V
Chene, G
Masquelier, B
Sicard, D
Brun-Vezinet, F
Reynes, J
Raffi, F
Citation: V. Le Moing et al., Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy, J ACQ IMM D, 24(1), 2000, pp. 82-83
Authors:
Masquelier, B
Boralevi, F
Mercie, P
Dupon, M
Fleury, HJA
Citation: B. Masquelier et al., Heterosexual transmission of Kaposi's sarcoma-associated herpes virus between two patients developing AIDS-Kaposi's sarcoma, AIDS, 14(4), 2000, pp. 471-472
Authors:
Masquelier, B
Descamps, D
Carriere, I
Ferchal, F
Collin, G
Denayrolles, M
Ruffault, A
Chanzy, B
Izopet, J
Buffet-Janvresse, C
Schmitt, MP
Race, E
Fleury, HJA
Aboulker, JP
Yeni, P
Brun-Vezinet, F
Citation: B. Masquelier et al., Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study, ANTIVIR TH, 4(2), 1999, pp. 69-77
Authors:
Beylot-Barry, M
Vergier, B
Masquelier, B
Bagot, M
Joly, P
Souteyrand, P
Vaillant, L
Avril, MF
Franck, N
Fraitag, S
Delaunay, M
Laroche, L
Esteve, E
Courville, P
Dechelotte, P
Beylot, C
De Mascarel, A
Wechsler, J
Merlio, JP
Citation: M. Beylot-barry et al., The spectrum of cutaneous lymphomas in HIV infection - A study of 21 cases, AM J SURG P, 23(10), 1999, pp. 1208-1216
Authors:
Lang, D
Hinderer, W
Rothe, M
Sonneborn, HH
Neipel, F
Raab, M
Rabenau, H
Masquelier, B
Fleury, H
Citation: D. Lang et al., Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8, VIROLOGY, 260(1), 1999, pp. 47-54